Immunotherapy

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway
Zelin Hou, Fengchun Lu, Jiajing Lin, Yuwei Wu, Linjin Chen, Haizong Fang, Linlin Chen, Shihan Zhang, Heguang Huang, Yu Pan

Journal for ImmunoTherapy of Cancer Sep 2024, 12 (9) e009318; DOI: 10.1136/jitc-2024-009318
Targeting IL-33 reprograms the tumor microenvironment and potentiates antitumor response to anti-PD-L1 immunotherapy
Yanyang Nan, Yu Bai, Xiaozhi Hu, Kaicheng Zhou, Tao Wu, An Zhu, Mengyang Li, Zihan Dou, Zhonglian Cao, Xumeng Zhang, Shuwen Xu, Yuanzhen Zhang, Jun Lin, Xian Zeng, Jiajun Fan, Xuyao Zhang, Xuebin Wang, Dianwen Ju

Journal for ImmunoTherapy of Cancer Sep 2024, 12 (9) e009236; DOI: 10.1136/jitc-2024-009236
Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study
Guanchao Ye, Guangyao Wu, Yu Qi, Kuo Li, Mingliang Wang, Chunyang Zhang, Feng Li, Leonard Wee, Andre Dekker, Chu Han, Zaiyi Liu, Yongde Liao, Zhenwei Shi

Journal for ImmunoTherapy of Cancer Sep 2024, 12 (9) e009348; DOI: 10.1136/jitc-2024-009348
Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment
Brenda C O'Connell, Charley Hubbard, Nora Zizlsperger, Donna Fitzgerald, Jeffrey L Kutok, Judith Varner, Robert Ilaria, Melody A Cobleigh, Dejan Juric, Kate H R Tkaczuk, Anthony Elias, Arielle Lee, Shaker Dakhil, Erika Hamilton, Hatem Soliman, Stephane Peluso

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009160; DOI: 10.1136/jitc-2024-009160
Immune modulatory microRNAs in tumors, their clinical relevance in diagnosis and therapy
Christoforos Vaxevanis, Michael Bachmann, Barbara Seliger

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009774; DOI: 10.1136/jitc-2024-009774
Immune checkpoint blockade: timing is everything
Frank A Sinicrope, Mary Jo Turk

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009722; DOI: 10.1136/jitc-2024-009722
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumab
Anna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, Miklos C Fogarasi, Patrick A Ott, F Stephen Hodi, Tamara A Sussman, Ann W Silk, Rizwan Haq, David Liu, Megan Insco, Elizabeth I Buchbinder

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009061; DOI: 10.1136/jitc-2024-009061
Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy
Congwen Wang, Lewei He, Jing Peng, Chong Lu, Meng Zhang, Xingling Qi, Mingxing Zhang, Yumeng Wang

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009404; DOI: 10.1136/jitc-2024-009404
Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors
Fei Zhu, Zheng Lu, Wenjing Tang, Guangya Zhao, Yingxiang Shao, Bowen Lu, Jiage Ding, Yanyan Zheng, Lin Fang, Huizhong Li, Gang Wang, Renjin Chen, Junnian Zheng, Dafei Chai

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009869; DOI: 10.1136/jitc-2024-009869
Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018–2022
Colm Mac Eochagain, Robert Power, Christine Sam, Nicolas M Gonzalez-Senac, Darren Walsh, Mukul Roy, Nicolò Matteo Luca Battisti

Journal for ImmunoTherapy of Cancer Aug 2024, 12 (8) e009258; DOI: 10.1136/jitc-2024-009258

Main menu

Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunotherapy

Pages